Copyright © Inderes 2011 - present. All rights reserved.

Newbury Pharmaceuticals

1.52 SEK

-0.33 %

Less than 1K followers

NEWBRY

First North Stockholm

Medical Equipment & Services

Health Care

-0.33 %
-27.86 %
-39.64 %
-40.59 %
-56.96 %
-55.18 %
-77.39 %
-
-87.98 %

Newbury Pharmaceuticals is a pharmaceutical company. The company develops a pipeline of in-house developed and licensed products with a focus on specialty drugs in areas such as oncology, rare diseases, and neurology. The company conducts its business within the Scandinavian market. Newbury Pharmaceuticals was founded in 2020 and has its headquarters in Lund.

Read more
Market cap
46.05M SEK
Turnover
21.79K SEK
Revenue
31.58M
EBIT %
-69.57 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
14/1
2026

General meeting '26

21/1
2026

Interim report Q1'26

15/4
2026

Interim report Q2'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.